Correlation Between China Pharma and Sunshine Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Pharma and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Pharma and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Pharma Holdings and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on China Pharma and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Pharma with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Pharma and Sunshine Biopharma.

Diversification Opportunities for China Pharma and Sunshine Biopharma

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between China and Sunshine is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding China Pharma Holdings and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and China Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Pharma Holdings are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of China Pharma i.e., China Pharma and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between China Pharma and Sunshine Biopharma

Given the investment horizon of 90 days China Pharma is expected to generate 8.68 times less return on investment than Sunshine Biopharma. But when comparing it to its historical volatility, China Pharma Holdings is 1.58 times less risky than Sunshine Biopharma. It trades about 0.03 of its potential returns per unit of risk. Sunshine Biopharma Warrant is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  19.00  in Sunshine Biopharma Warrant on November 4, 2024 and sell it today you would earn a total of  5.00  from holding Sunshine Biopharma Warrant or generate 26.32% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy80.0%
ValuesDaily Returns

China Pharma Holdings  vs.  Sunshine Biopharma Warrant

 Performance 
       Timeline  
China Pharma Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Pharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, China Pharma is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Sunshine Biopharma 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

China Pharma and Sunshine Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Pharma and Sunshine Biopharma

The main advantage of trading using opposite China Pharma and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Pharma position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.
The idea behind China Pharma Holdings and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.